XCells Biotechnologies USA, Inc. ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced the delivery of over 500 characterized induced pluripotent stem ...
Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.
Morning Overview on MSN
Japan approves world-first iPSC therapy for Parkinson’s disease
Japan’s health ministry has endorsed the first stem-cell therapy derived from induced pluripotent stem cells (iPSCs) for ...
Nina Bauer of FUJIFILM Cellular Dynamics shares insight on addressing challenges and supporting developers heading towards commercialization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results